Gujarat Narmada Valley Fertilizers & Chemicals Limited Board Announces Strong Financial Performance and 210% Dividend

Gujarat Narmada Valley Fertilizers & Chemicals Limited (GNFC) has announced robust audited financial results for the quarter and year ended March 31, 2026. The Board of Directors has recommended a final dividend of 210%, amounting to ₹21 per equity share. Driven by improved sales realizations and lower input costs, the company reported an annual standalone profit of ₹797 crore, demonstrating significant growth and operational resilience over the previous fiscal year.

Annual Financial Highlights

For the financial year ended March 31, 2026, GNFC reported a solid standalone revenue from operations of ₹7,773 crore. The net profit after tax reached ₹797 crore, marking a substantial increase compared to ₹585 crore in the previous fiscal year. This performance was bolstered by a strong final quarter (Jan-Mar 2026), which recorded a standalone net profit of ₹392 crore.

Dividend Recommendation

Reflecting the company’s strong financial health and commitment to shareholder value, the Board has recommended a dividend of ₹21 per equity share of face value ₹10, representing a 210% payout. This recommendation is subject to approval by shareholders at the upcoming Annual General Meeting. Upon approval, the dividend will be paid within 30 days.

Segmental Performance and Outlook

The company’s performance was driven by a strong showing in the Chemicals segment, which reported a full-year revenue of ₹4,899 crore. While the Fertilizer segment faced challenges, including higher energy norms and fixed costs, overall profitability was supported by lower input costs and improved operational efficiencies. Additionally, the company has appointed B S R and Co., Chartered Accountants, as the new Statutory Auditors for a five-year term.

Strategic Capital Expenditure

GNFC continues to invest in long-term growth through its active projects, including the Coal-based Steam & Power Plant (CCPP), Ammonia Expansion at Bharuch, and Weak Nitric Acid III. These projects, currently under execution, are designed to improve operating margins and strengthen the company’s market position, aligning with a forward-looking strategy to add both top-line and bottom-line growth organically.

Source: BSE

Previous Article

Syrma SGS Technology Limited Landmark Performance for FY 2026 with Strong Growth Across Verticals

Next Article

Imagicaaworld Entertainment Limited Annual Secretarial Compliance Report Released